アンチセンス&RNAi治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Antisense & RNAi Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100250)・商品コード:GIR8100250
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年8月29日
・ページ数:152
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥365,400見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥548,100見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥730,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、アンチセンス&RNAi治療の世界市場について調べ、まとめました。種類別セグメントは、RNA干渉、SiRNA、MiRNA、アンチセンスRNA等、用途別セグメントは、腫瘍学、心臓血管、腎臓、神経変性、呼吸器、その他等に区分しました。アンチセンス&RNAi治療の世界市場概観、メーカー動向、メーカー別アンチセンス&RNAi治療シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・アンチセンス&RNAi治療の市場概観
・アンチセンス&RNAi治療のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・アンチセンス&RNAi治療のメーカー別販売動向、市場シェア、市場集中度、競争動向
・アンチセンス&RNAi治療の世界市場規模
・アンチセンス&RNAi治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・アンチセンス&RNAi治療のアメリカ市場規模推移
・アンチセンス&RNAi治療のカナダ市場規模推移
・アンチセンス&RNAi治療のメキシコ市場規模推移
・アンチセンス&RNAi治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・アンチセンス&RNAi治療のドイツ市場規模推移
・アンチセンス&RNAi治療のイギリス市場規模推移
・アンチセンス&RNAi治療のロシア市場規模推移
・アンチセンス&RNAi治療のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・アンチセンス&RNAi治療の日本市場規模推移
・アンチセンス&RNAi治療の中国市場規模推移
・アンチセンス&RNAi治療の韓国市場規模推移
・アンチセンス&RNAi治療のインド市場規模推移
・アンチセンス&RNAi治療の東南アジア市場規模推移
・アンチセンス&RNAi治療の南米市場分析(ブラジル、アルゼンチン等)
・アンチセンス&RNAi治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・アンチセンス&RNAi治療の種類別分析/市場規模推移(RNA干渉、SiRNA、MiRNA、アンチセンスRNA)
・アンチセンス&RNAi治療の用途別分析/市場規模推移(腫瘍学、心臓血管、腎臓、神経変性、呼吸器、その他)
・アンチセンス&RNAi治療の市場予測(地域別予測、種類別予測、用途別予測)
・アンチセンス&RNAi治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene “off”.

Scope of the Report:

This report studies the Antisense & RNAi Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antisense & RNAi Therapeutics market by product type and applications/end industries.

North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.

The global Antisense & RNAi Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antisense & RNAi Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Glaxo Smith Kline

Sanofi Aventis / Genzyme

Isis Pharmaceuticals/ Ionis Pharmaceuticals

Arbutus Biopharma Ltd.

Silence Therapeutics

Bio-Path Holdings Inc.

Calando Pharmaceuticals

ICo Therapeutics

Quark Pharmaceuticals

Rexhan Pharmaceuticals

Biomarin/Prosensa

Regulus Therapeutics

Rxi Pharmaceuticals

Silenseed

Dicerna Pharmaceuticals

Sirnaomics Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

RNA interference

SiRNA

MiRNA

Antisense RNA

Market Segment by Applications, can be divided into

Oncology

Cardiovascular

Renal

Neurodegenerative

Respiratory

Genetic

Infectious Diseases

【レポートの目次】

Table of Contents

1 Antisense & RNAi Therapeutics Market Overview

1.1 Product Overview and Scope of Antisense & RNAi Therapeutics

1.2 Classification of Antisense & RNAi Therapeutics by Types

1.2.1 Global Antisense & RNAi Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Types in 2017

1.2.3 RNA interference

1.2.4 SiRNA

1.2.5 MiRNA

1.2.6 Antisense RNA

1.3 Global Antisense & RNAi Therapeutics Market by Application

1.3.1 Global Antisense & RNAi Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Renal

1.3.5 Neurodegenerative

1.3.6 Respiratory

1.3.7 Genetic

1.3.8 Infectious Diseases

1.4 Global Antisense & RNAi Therapeutics Market by Regions

1.4.1 Global Antisense & RNAi Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Antisense & RNAi Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 Glaxo Smith Kline

2.1.1 Business Overview

2.1.2 Antisense & RNAi Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Sanofi Aventis / Genzyme

2.2.1 Business Overview

2.2.2 Antisense & RNAi Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals

2.3.1 Business Overview

2.3.2 Antisense & RNAi Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Arbutus Biopharma Ltd.

2.4.1 Business Overview

2.4.2 Antisense & RNAi Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Silence Therapeutics

2.5.1 Business Overview

2.5.2 Antisense & RNAi Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bio-Path Holdings Inc.

2.6.1 Business Overview

2.6.2 Antisense & RNAi Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 Calando Pharmaceuticals

2.7.1 Business Overview

2.7.2 Antisense & RNAi Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 ICo Therapeutics

2.8.1 Business Overview

2.8.2 Antisense & RNAi Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 ICo Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.9 Quark Pharmaceuticals

2.9.1 Business Overview

2.9.2 Antisense & RNAi Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.10 Rexhan Pharmaceuticals

2.10.1 Business Overview

2.10.2 Antisense & RNAi Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.11 Biomarin/Prosensa

2.11.1 Business Overview

2.11.2 Antisense & RNAi Therapeutics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.12 Regulus Therapeutics

2.12.1 Business Overview

2.12.2 Antisense & RNAi Therapeutics Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Regulus Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.13 Rxi Pharmaceuticals

2.13.1 Business Overview

2.13.2 Antisense & RNAi Therapeutics Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.14 Silenseed

2.14.1 Business Overview

2.14.2 Antisense & RNAi Therapeutics Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Silenseed Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.15 Dicerna Pharmaceuticals

2.15.1 Business Overview

2.15.2 Antisense & RNAi Therapeutics Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.16 Sirnaomics Inc.

2.16.1 Business Overview

2.16.2 Antisense & RNAi Therapeutics Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Antisense & RNAi Therapeutics Market Competition, by Players

3.1 Global Antisense & RNAi Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Antisense & RNAi Therapeutics Players Market Share

3.2.2 Top 10 Antisense & RNAi Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Antisense & RNAi Therapeutics Market Size by Regions

4.1 Global Antisense & RNAi Therapeutics Revenue and Market Share by Regions

4.2 North America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Antisense & RNAi Therapeutics Revenue by Countries

5.1 North America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)

5.2 USA Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Antisense & RNAi Therapeutics Revenue by Countries

6.1 Europe Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries

7.1 Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)

7.2 China Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Antisense & RNAi Therapeutics Revenue by Countries

8.1 South America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Antisense & RNAi Therapeutics by Countries

9.1 Middle East and Africa Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Antisense & RNAi Therapeutics Market Segment by Type

10.1 Global Antisense & RNAi Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Antisense & RNAi Therapeutics Market Forecast by Type (2018-2023)

10.3 RNA interference Revenue Growth Rate (2013-2023)

10.4 SiRNA Revenue Growth Rate (2013-2023)

10.5 MiRNA Revenue Growth Rate (2013-2023)

10.6 Antisense RNA Revenue Growth Rate (2013-2023)

11 Global Antisense & RNAi Therapeutics Market Segment by Application

11.1 Global Antisense & RNAi Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Antisense & RNAi Therapeutics Market Forecast by Application (2018-2023)

11.3 Oncology Revenue Growth (2013-2018)

11.4 Cardiovascular Revenue Growth (2013-2018)

11.5 Renal Revenue Growth (2013-2018)

11.6 Neurodegenerative Revenue Growth (2013-2018)

11.7 Respiratory Revenue Growth (2013-2018)

11.8 Genetic Revenue Growth (2013-2018)

11.9 Infectious Diseases Revenue Growth (2013-2018)

12 Global Antisense & RNAi Therapeutics Market Size Forecast (2018-2023)

12.1 Global Antisense & RNAi Therapeutics Market Size Forecast (2018-2023)

12.2 Global Antisense & RNAi Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Antisense & RNAi Therapeutics Picture

Table Product Specifications of Antisense & RNAi Therapeutics

Table Global Antisense & RNAi Therapeutics and Revenue (Million USD) Market Split by Product Type

Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Types in 2017

Figure RNA interference Picture

Figure SiRNA Picture

Figure MiRNA Picture

Figure Antisense RNA Picture

Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Application (2013-2023)

Figure Antisense & RNAi Therapeutics Revenue Market Share by Applications in 2017

Figure Oncology Picture

Figure Cardiovascular Picture

Figure Renal Picture

Figure Neurodegenerative Picture

Figure Respiratory Picture

Figure Genetic Picture

Figure Infectious Diseases Picture

Table Global Market Antisense & RNAi Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)

Table Glaxo Smith Kline Basic Information, Manufacturing Base and Competitors

Table Glaxo Smith Kline Antisense & RNAi Therapeutics Type and Applications

Table Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Aventis / Genzyme Basic Information, Manufacturing Base and Competitors

Table Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Type and Applications

Table Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications

Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Arbutus Biopharma Ltd. Basic Information, Manufacturing Base and Competitors

Table Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Type and Applications

Table Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Silence Therapeutics Basic Information, Manufacturing Base and Competitors

Table Silence Therapeutics Antisense & RNAi Therapeutics Type and Applications

Table Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Bio-Path Holdings Inc. Basic Information, Manufacturing Base and Competitors

Table Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Type and Applications

Table Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Calando Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Calando Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications

Table Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table ICo Therapeutics Basic Information, Manufacturing Base and Competitors

Table ICo Therapeutics Antisense & RNAi Therapeutics Type and Applications

Table ICo Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Quark Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications

Table Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Rexhan Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications

Table Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Biomarin/Prosensa Basic Information, Manufacturing Base and Competitors

Table Biomarin/Prosensa Antisense & RNAi Therapeutics Type and Applications

Table Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Regulus Therapeutics Basic Information, Manufacturing Base and Competitors

Table Regulus Therapeutics Antisense & RNAi Therapeutics Type and Applications

Table Regulus Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Rxi Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Rxi Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications

Table Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Silenseed Basic Information, Manufacturing Base and Competitors

Table Silenseed Antisense & RNAi Therapeutics Type and Applications

Table Silenseed Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications

Table Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Sirnaomics Inc. Basic Information, Manufacturing Base and Competitors

Table Sirnaomics Inc. Antisense & RNAi Therapeutics Type and Applications

Table Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Players (2013-2018)

Table Global Antisense & RNAi Therapeutics Revenue Share by Players (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue Share by Players in 2016

Figure Global Antisense & RNAi Therapeutics Revenue Share by Players in 2017

Figure Global Top 5 Players Antisense & RNAi Therapeutics Revenue Market Share in 2017

Figure Global Top 10 Players Antisense & RNAi Therapeutics Revenue Market Share in 2017

Figure Global Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Regions (2013-2018)

Table Global Antisense & RNAi Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Regions (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Regions in 2017

Figure North America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Europe Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure South America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Table North America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)

Table North America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure North America Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017

Figure USA Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Canada Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Mexico Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Table Europe Antisense & RNAi Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Europe Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Europe Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017

Figure Germany Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure UK Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure France Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Russia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Italy Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Antisense & RNAi Therapeutics Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017

Figure China Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Japan Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Korea Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure India Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Table South America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)

Table South America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure South America Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017

Figure Brazil Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Argentina Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Colombia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Antisense & RNAi Therapeutics Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017

Figure Saudi Arabia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure UAE Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Egypt Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure Nigeria Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Figure South Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)

Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Type (2013-2018)

Table Global Antisense & RNAi Therapeutics Revenue Share by Type (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue Share by Type (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue Share by Type in 2017

Table Global Antisense & RNAi Therapeutics Revenue Forecast by Type (2018-2023)

Figure Global Antisense & RNAi Therapeutics Market Share Forecast by Type (2018-2023)

Figure Global RNA interference Revenue Growth Rate (2013-2018)

Figure Global SiRNA Revenue Growth Rate (2013-2018)

Figure Global MiRNA Revenue Growth Rate (2013-2018)

Figure Global Antisense RNA Revenue Growth Rate (2013-2018)

Table Global Antisense & RNAi Therapeutics Revenue by Application (2013-2018)

Table Global Antisense & RNAi Therapeutics Revenue Share by Application (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue Share by Application (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue Share by Application in 2017

Table Global Antisense & RNAi Therapeutics Revenue Forecast by Application (2018-2023)

Figure Global Antisense & RNAi Therapeutics Market Share Forecast by Application (2018-2023)

Figure Global Oncology Revenue Growth Rate (2013-2018)

Figure Global Cardiovascular Revenue Growth Rate (2013-2018)

Figure Global Renal Revenue Growth Rate (2013-2018)

Figure Global Neurodegenerative Revenue Growth Rate (2013-2018)

Figure Global Respiratory Revenue Growth Rate (2013-2018)

Figure Global Genetic Revenue Growth Rate (2013-2018)

Figure Global Infectious Diseases Revenue Growth Rate (2013-2018)

Figure Global Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Antisense & RNAi Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Antisense & RNAi Therapeutics Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

Figure Europe Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

Figure South America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)



【レポートのキーワード】

アンチセンス&RNAi治療、RNA干渉、SiRNA、MiRNA、アンチセンスRNA、腫瘍学、心臓血管、腎臓、神経変性、呼吸器、その他

★調査レポート[アンチセンス&RNAi治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100250)販売に関する免責事項を必ずご確認ください。
★調査レポート[アンチセンス&RNAi治療の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆